Related Experiment Video
Updated: Dec 28, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Temporal association between serious bleeding and immunization: vitamin K deficiency as main causative factor
Susi Susanah1,2, Eddy Fadlyana3, Meita Dhamayanti3
1Department of Child Health, Dr. Hasan Sadikin General Hospital/Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia. susi_rshs@yahoo.co.id.
Insights
Bleeding events reported as adverse events following immunization (AEFI) in Indonesian children were mostly vitamin K deficiency bleeding (VKDB), unrelated to vaccination. Improved AEFI surveillance and routine vitamin K prophylaxis for newborns are recommended.
Area of Science:
- Pediatrics
- Immunology
- Hematology
Background:
- Bleeding is a rare but concerning adverse event following immunization (AEFI) in children.
- Bleeding episodes can stem from various acquired or hereditary disorders.
- This study investigates the causal association between immunization and bleeding episodes in children recorded as AEFIs.
Purpose of the Study:
- To analyze bleeding episodes in children reported as AEFIs.
- To determine the etiological factors of these bleeding episodes.
- To assess the causal relationship between immunization and bleeding events.
Main Methods:
- A cross-sectional study of 388 AEFI cases in children in West Java, Indonesia (2000-2017).
- Case findings and confirmation were conducted.
- Causality assessment using the World Health Organization classification.
Main Results:
- 55 children (14%) presented with bleeding as an AEFI.
- 32 cases were attributed to acquired prothrombin complex deficiency (APCD), with 30 suspected as vitamin K deficiency bleeding (VKDB).
- Most bleeding cases were deemed coincidental events with a temporal association to immunization, causally unrelated.
Conclusions:
- The majority of bleeding AEFIs in this cohort were identified as VKDB, coincidental with immunization.
- A causal relationship between immunization and these bleeding events was not established.
- Recommendations include vitamin K administration to all newborns and improved AEFI surveillance in Indonesia.
Background:
Bleeding as an adverse event following immunization (AEFI) that is rarely reported in children, although it can be a parental concern. Bleeding episodes ranging in severity from mild to severe and defined as any external and/or internal bleeding can be caused by acquired or hereditary disorders. This study analyzes whether bleeding episodes in children that were recorded as AEFIs are causally associated with immunization and elaborates their etiology.
Methods:
A cross-sectional study of 388 AEFI cases in children from West Java Provincial Committee in Indonesia confirmed by case findings from 2000 until 2017.
Results:
Of the total number of cases studied, 55 (14%) involved children aged 5 days to 12 years who presented with bleeding and were referred to a provincial hospital. Analysis revealed that 32 cases were most likely caused by acquired prothrombin complex deficiency (APCD) and 30 of these APCD cases were strongly suspected to be manifestations of vitamin K deficiency bleeding (VKDB). All VKDB subjects were aged 5 days to 3 months without a history of administration of prophylactic vitamin K. When a World Health Organization classification was used, most bleeding cases in this study became coincidental events with a temporal association with immunization. A causality assessment suggested that these cases were causally unrelated.
Conclusion:
Most cases of bleeding reported as an AEFI were found to be VKDB, which is considered a coincidental event following immunization with a temporal association, and an unrelated category based on the results of a causality assessment. Vitamin K should be administered to all newborns as a prophylactic and AEFI surveillance should be improved based on the low numbers of AEFI reported in Indonesia.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Vitamins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

